A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma
Background The optimal treatment method for papillary thyroid microcarcinoma (PTMC) is lacking consensus. Here we aimed to compare the efficacy and safety of surgery and microwave ablation (MWA) for PTMC. Methods The clinical data of 644 patients with PTMC treated between July 2013 and June 2020 wer...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Taylor & Francis Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/8eae52283b1c43ef8a8c5837d2a664ce |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:8eae52283b1c43ef8a8c5837d2a664ce |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:8eae52283b1c43ef8a8c5837d2a664ce2021-11-04T15:00:41ZA cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma0265-67361464-515710.1080/02656736.2021.1996643https://doaj.org/article/8eae52283b1c43ef8a8c5837d2a664ce2021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/02656736.2021.1996643https://doaj.org/toc/0265-6736https://doaj.org/toc/1464-5157Background The optimal treatment method for papillary thyroid microcarcinoma (PTMC) is lacking consensus. Here we aimed to compare the efficacy and safety of surgery and microwave ablation (MWA) for PTMC. Methods The clinical data of 644 patients with PTMC treated between July 2013 and June 2020 were retrospectively analyzed. A total of 320 and 324 patients underwent MWA and surgery, respectively. We observed lesion changes in the MWA group and compared the recurrence, metastasis, complications, and other health economic indicators between the 2 groups. Results The mean follow-up time was 890.7 ± 532.9 (187.9–2679.0) days in the MWA group and 910.9 ± 568.4 (193.8–2821.5) days in the surgery group. In the MWA group, lesion volume increased significantly after ablation and then gradually decreased. The final lesion volume reduction rate was 90.73% ± 7.94%, and 193 lesions (60.3%) disappeared completely. There were no significant intergroup differences in recurrence or metastasis. The incidence of main complications (temporary hypothyroidism, hypoparathyroidism, and temporary hoarseness) was significantly lower in the MWA group than in the surgery group (p < 0.001). The treatment time, intraoperative blood loss, and hospital stay were significantly lower in the MWA group than in the surgery group (p < 0.001). Conclusions MWA is effective for treating PTMC, with a low incidence of complications and less trauma. The rates of post-treatment recurrence and metastasis are similar to those of surgery, indicating that MWA is a suitable alternative to surgery.Yuan ZuYujiang LiuJunfeng ZhaoPeipei YangJianming LiLinxue QianTaylor & Francis Grouparticlecomplicationsmicrowave ablationpapillary thyroid microcarcinomathyroid glandthyroidectomyMedical technologyR855-855.5ENInternational Journal of Hyperthermia, Vol 38, Iss 1, Pp 1548-1557 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
complications microwave ablation papillary thyroid microcarcinoma thyroid gland thyroidectomy Medical technology R855-855.5 |
| spellingShingle |
complications microwave ablation papillary thyroid microcarcinoma thyroid gland thyroidectomy Medical technology R855-855.5 Yuan Zu Yujiang Liu Junfeng Zhao Peipei Yang Jianming Li Linxue Qian A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma |
| description |
Background The optimal treatment method for papillary thyroid microcarcinoma (PTMC) is lacking consensus. Here we aimed to compare the efficacy and safety of surgery and microwave ablation (MWA) for PTMC. Methods The clinical data of 644 patients with PTMC treated between July 2013 and June 2020 were retrospectively analyzed. A total of 320 and 324 patients underwent MWA and surgery, respectively. We observed lesion changes in the MWA group and compared the recurrence, metastasis, complications, and other health economic indicators between the 2 groups. Results The mean follow-up time was 890.7 ± 532.9 (187.9–2679.0) days in the MWA group and 910.9 ± 568.4 (193.8–2821.5) days in the surgery group. In the MWA group, lesion volume increased significantly after ablation and then gradually decreased. The final lesion volume reduction rate was 90.73% ± 7.94%, and 193 lesions (60.3%) disappeared completely. There were no significant intergroup differences in recurrence or metastasis. The incidence of main complications (temporary hypothyroidism, hypoparathyroidism, and temporary hoarseness) was significantly lower in the MWA group than in the surgery group (p < 0.001). The treatment time, intraoperative blood loss, and hospital stay were significantly lower in the MWA group than in the surgery group (p < 0.001). Conclusions MWA is effective for treating PTMC, with a low incidence of complications and less trauma. The rates of post-treatment recurrence and metastasis are similar to those of surgery, indicating that MWA is a suitable alternative to surgery. |
| format |
article |
| author |
Yuan Zu Yujiang Liu Junfeng Zhao Peipei Yang Jianming Li Linxue Qian |
| author_facet |
Yuan Zu Yujiang Liu Junfeng Zhao Peipei Yang Jianming Li Linxue Qian |
| author_sort |
Yuan Zu |
| title |
A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma |
| title_short |
A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma |
| title_full |
A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma |
| title_fullStr |
A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma |
| title_full_unstemmed |
A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma |
| title_sort |
cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma |
| publisher |
Taylor & Francis Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/8eae52283b1c43ef8a8c5837d2a664ce |
| work_keys_str_mv |
AT yuanzu acohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT yujiangliu acohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT junfengzhao acohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT peipeiyang acohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT jianmingli acohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT linxueqian acohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT yuanzu cohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT yujiangliu cohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT junfengzhao cohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT peipeiyang cohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT jianmingli cohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma AT linxueqian cohortstudyofmicrowaveablationandsurgeryforlowriskpapillarythyroidmicrocarcinoma |
| _version_ |
1718444785630445568 |